Literature DB >> 29295877

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Shaji K Kumar, Natalie S Callander, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Jorge Castillo, Jason C Chandler, Caitlin Costello, Matthew Faiman, Henry C Fung, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah Holstein, Carol Ann Huff, Yubin Kang, Adetola Kassim, Michaela Liedtke, Ehsan Malek, Thomas Martin, Vishala T Neppalli, James Omel, Noopur Raje, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Donna Weber, Joachim Yahalom, Rashmi Kumar, Dorothy A Shead.   

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
Copyright © 2018 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Year:  2018        PMID： 29295877     DOI： 10.6004/jnccn.2018.0002

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  28 in total

Review 1.  Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.

Authors:  Tanya M Wildes; Kenneth C Anderson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients.

Authors:  Sergio Giralt; Eric Seifter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.

Authors:  Andrea Schmidts; Maria Ormhøj; Bryan D Choi; Allison O Taylor; Amanda A Bouffard; Irene Scarfò; Rebecca C Larson; Matthew J Frigault; Kathleen Gallagher; Ana P Castano; Lauren S Riley; Maria L Cabral; Angela C Boroughs; Rubí M-H Velasco Cárdenas; Wolfgang Schamel; Jing Zhou; Sean Mackay; Yu-Tzu Tai; Kenneth C Anderson; Marcela V Maus
Journal:  Blood Adv       Date:  2019-11-12

Review 4.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

5.  How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.

Authors:  Matthew R LeBlanc; Rachel Hirschey; Ashley Leak Bryant; Thomas W LeBlanc; Sophia K Smith
Journal:  Qual Life Res       Date:  2019-12-17       Impact factor: 4.147

6.  miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.

Authors:  Xiaoli Yuan; Rongjun Ma; Shiwei Yang; Li Jiang; Zhen Wang; Zunmin Zhu; Hongwei Li
Journal:  Cell Cycle       Date:  2019-06-20       Impact factor: 4.534

7.  [The influence of apolipoprotein A1 on the prognosis of multiple myeloma].

Authors:  J Shen; R H Yang; Y C Zhang; A J Liao; Z G Liu; W Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

8.  Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.

Authors:  Sergio Giralt; Luciano J Costa; David Maloney; Amrita Krishnan; Mingwei Fei; Joseph H Antin; Claudio Brunstein; Nancy Geller; Stacey Goodman; Parameswaran Hari; Brent Logan; Robert Lowsky; Muzaffar H Qazilbash; Firoozeh Sahebi; George Somlo; Scott Rowley; Dan T Vogl; David H Vesole; Marcelo Pasquini; Edward Stadtmauer
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-19       Impact factor: 5.742

9.  Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.

Authors:  Vanessa Piechotta; Tina Jakob; Peter Langer; Ina Monsef; Christof Scheid; Lise J Estcourt; Sunday Ocheni; Sebastian Theurich; Kathrin Kuhr; Benjamin Scheckel; Anne Adams; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2019-11-25

10.  Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.

Authors:  Rosanne Janssens; Tamika Lang; Ana Vallejo; Jayne Galinsky; Ananda Plate; Kate Morgan; Elena Cabezudo; Raija Silvennoinen; Daniel Coriu; Sorina Badelita; Ruxandra Irimia; Minna Anttonen; Riikka-Leena Manninen; Elise Schoefs; Martina Vandebroek; Anneleen Vanhellemont; Michel Delforge; Hilde Stevens; Steven Simoens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.